GNI Ltd.
日本語
Company
Therapeutic Areas
Products/Pipeline
R&D
Careers
News
Stock
stock quote
GNI Group in News
Events
Media Coverage
TSE Filings
Financial Reports
analystcoverage
FAQ
Information Request
Top
>
Investors and Media
> GNI in News
2007 News Releases
GNI has also attracted significant interest from the mainstream business Japanese media. To view a selection of articles, please visit our
Japanese website
.
Date
Title
Sep 25, 2008
GNI Announces Strategy for Seeking Early Conditional Approval of F647 for the treatment of Idiopathic Pulmonary Fibrosis in China
Aug 1, 2008
GNI Announces Restructuring to Streamline Operation and to Reduce Cost; CEO Luo Succeeds President
July 30, 2008
New Ubiquitin-Mediated Protein Degradation Mechanism Published by Scientists in Shanghai
July 16, 2008
EpiCept and GNI Form Partnership to Develop Liver Disease Drug in Asia
June 30, 2008
GNI Announces Election of New Directors and Auditor
June 19, 2008
GNI Signs Binding Term Sheet to Raise Capital
June 18, 2008
GNI’s F647 Shows Positive Results in Phase U Human Clinical Trial of Idiopathic Pulmonary Fibrosis
May 20, 2008
GNI Announces Donation to Earthquake Area of China
May 19, 2008
GNI Signs Term Sheet to Acquire Hengshan Pharmaceuticals of Shanghai, China
May 16, 2008
China Patent and Trade Mark Office Grants Patent for RX50, a Drug Target Implicated in Human Cancers and Neurodegenerative Disorders
May 8, 2008
GNI to present at IBC’s 3rd Annual International Conference and Exhibition
Mar 31, 2008
GNI and Organon Extend and Expand Collaborative Research
Mar 18, 2008
GNI Scientists Complete Three Grant Projects for Drug Target Discovery in China
Dec 21, 2007
Phase I Human Trial of F351 Initiated in China
Nov 7, 2007
China Patent and Trademark Office Grants Patent for F351,GNI's Key Therapeutic Product for Liver Disease
Oct 25, 2007
GNI Receives Patent Approval in China for Important Cancer Targets
Oct 17, 2007
GNI Researchers in China Identify Important New Regulator of Inflammation
Oct 11, 2007
GNI Ranked Number Six in the 2007 Deloitte FAST 50
Sep 3, 2007
GNI Successfully Completes IPO
Jan 18, 2007
GNI Forms Marketing Alliance with Wako Pure Chemical
Move to grow sales of Cell Illustrator 3.0
Apr 11, 2006
GNI and Beijing Continent Pharmaceutical Agree to Form Strategic Alliance
Mar 24, 2006
GNI Launches the GNI Systems Pharmacology Research Institute in Fukuoka